2. Cell Cycle/DNA Damage
  3. IRE1
  4. MKC8866

MKC8866, un analogue du salicylaldéhyde, est un inhibiteur de IRE1 RNase qui est puissant et sélectif avec un IC50 de 0,29 μM in vitro humaine. MKC8866 inhibe fortement l'expression de la protéine X-box-binding protein 1-spliced (XBP1s) induite par le dithiothréitol avec un EC50 de 0,52 μM et soulage les cellules RPMI 8226 avec un IC50 de 0,14 μM. MKC8866 inhibe la RNase IRE1 dans les cellules cancéreuses du sein, ce qui entraîne une diminution de la production de facteurs pro-tumorigènes et peut inhiber la croissance tumorale du cancer de la prostate (PCa).

MKC8866, a salicylaldehyde analog, is a potent, selective IRE1 RNase inhibitor with an IC50 of 0.29?μM in human vitro. MKC8866 strongly inhibits Dithiothreitol-induced X-box-binding protein 1-spliced (XBP1s) expression with an EC50 of 0.52?μM and unstresses RPMI 8226 cells with an IC50 of 0.14?μM. MKC8866 inhibits IRE1 RNase in breast cancer cells leading to the decreased production of pro-tumorigenic factors and it can inhibits prostate cancer (PCa) tumor growth.

For research use only. We do not sell to patients.

MKC8866 Chemical Structure

MKC8866 Chemical Structure

CAS No. : 1338934-59-0

Size Price Stock Quantity
Free Sample (0.1 - 0.5 mg)   Apply Now  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
 USD 264 In-stock
Solution
10 mM * 1 mL in DMSO USD 264 In-stock
Solid
5 mg USD 240 In-stock
10 mg USD 390 In-stock
25 mg USD 740 In-stock
50 mg USD 1110 In-stock
100 mg USD 1660 In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 9 publication(s) in Google Scholar

MKC8866 Related Antibodies

Top Publications Citing Use of Products

    MKC8866 purchased from MedChemExpress. Usage Cited in: Cancer Lett. 2020 Oct 10;490:76-88.  [Abstract]

    RH30 and RD cells are treated with MKC8866 (20 μM) and/or AMGEN44 (2 μM) for 72 hours and Western blot confirmes IRE1 and PERK signalling inhibition. In cells treated with AMGEN44 alone or in combination with MKC8866, PERK phosphorylation is reduced and p-eIF2α protein levels are diminished. In cells treated with MKC8866 alone or in combination with AMGEN44, XBP1s protein levels are completely abolished.

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    MKC8866, a salicylaldehyde analog, is a potent, selective IRE1 RNase inhibitor with an IC50 of 0.29?μM in human vitro. MKC8866 strongly inhibits Dithiothreitol-induced X-box-binding protein 1-spliced (XBP1s) expression with an EC50 of 0.52?μM and unstresses RPMI 8226 cells with an IC50 of 0.14?μM[1]. MKC8866 inhibits IRE1 RNase in breast cancer cells leading to the decreased production of pro-tumorigenic factors and it can inhibits prostate cancer (PCa) tumor growth[2].

    IC50 & Target

    IC50: 0.29 μM (IRE1 RNase)[1]
    In Vitro

    MKC8866 (20 μM; 6 days) decreases proliferation of all breast cancer cell lines[2].
    MKC8866 (20 μM; 48 hours) reduces the number of cells entering S phase[2].
    MKC8866 (0.2-10 μM; 3 days) suppresses the viability of all four cell lines in a dose-dependent manner under normal conditions, with the most robust effect in LNCaP cells[1].
    MKC8866 (20 μM; 72 hours) is sufficient to completely block NSC 125973-induced expression of XBP1s [1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    MKC8866 Related Antibodies

    Cell Proliferation Assay[2]

    Cell Line: MCF7, SKBR3, MDA-MB-231 and MCF10A cells
    Concentration: 20 μM
    Incubation Time: For 6 days
    Result: Decreased proliferation of all breast cancer cell lines.

    Cell Cycle Analysis[2]

    Cell Line: MDA-MB-231, MCF7 and SKBR3 cells
    Concentration: 20 μM
    Incubation Time: 48 hours
    Result: Reduced the number of cells entering S phase.

    Cell Cycle Analysis[1]

    Cell Line: LNCaP, VCaP, 22Rv1 and C4-2B cells
    Concentration: 0.2, 0.5, 1, 5, 10 μM
    Incubation Time: 3 days
    Result: Suppressed the viability of all four cell lines in a dose-dependent manner.

    Cell Cycle Analysis[2]

    Cell Line: MDA-MB-231 cells
    Concentration: 20 μM
    Incubation Time: 72  hours
    Result: Completely blocked NSC 125973-induced expression of XBP1s.
    In Vivo

    MKC8866 (oral ; 300 mg/kg; for 28 days) reduces tumor regrowth post-NSC 125973 withdrawal[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Female athymic nude mice with MDA-MB-231 tumor[1]
    Dosage: 300 mg/kg
    Administration: Oral; for 28 days
    Result: Reduced tumor regrowth post-NSC 125973 withdrawal.
    Clinical Trial
    Molecular Weight

    361.35

    Formula

    C18H19NO7
    CAS No.
    Appearance

    Solid

    Color

    Light yellow to yellow

    SMILES

    O=CC1=C(O2)C(C(C)=C(CC(N3CCOCC3)=O)C2=O)=CC(OC)=C1O
    Shipping

    Room temperature in continental US; may vary elsewhere.
    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 6 months
    -20°C 1 month
    Solvent & Solubility
    In Vitro: 

    DMSO : 6.67 mg/mL (18.46 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.7674 mL 13.8370 mL 27.6740 mL
    5 mM 0.5535 mL 2.7674 mL 5.5348 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    Purity & Documentation

    Purity: 99.95%

    SDS (393 KB)

    COA (249 KB) HNMR (112 KB) RP-HPLC (249 KB) MS (110 KB)

    Handling Instructions (2659 KB)
    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 2.7674 mL 13.8370 mL 27.6740 mL 69.1850 mL
    5 mM 0.5535 mL 2.7674 mL 5.5348 mL 13.8370 mL
    10 mM 0.2767 mL 1.3837 mL 2.7674 mL 6.9185 mL
    15 mM 0.1845 mL 0.9225 mL 1.8449 mL 4.6123 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    MKC8866 Related Classifications

    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Keywords:

    MKC88661338934-59-0Orin1001MKC 8866MKC-8866Orin 1001Orin-1001IRE1Inositol requiring enzyme 1Inhibitorinhibitorinhibit

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Salutation

    Applicant Name *

    		 

    Email Address *

    Phone Number *

    		 

    Organization Name *

    Department *

    		 

    Requested quantity *

    Country or Region *

    		      

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    MKC8866
    Cat. No.:
    HY-104040
    Quantity:
    MCE Japan Authorized Agent:

    Customer Review

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Lot #

    Applicant Name *

    		 

    Email Address *

    Phone Number

    		 

    Department *

    Organization Name *

    		 

    Country or Region *

    Remarks

    SAFETY DATA SHEET (SDS)

    English - EN (393 KB) Français - FR (393 KB) Deutsch - DE (393 KB) Norwegian - NO (393 KB) Español - ES (393 KB) Swedish - SV (393 KB)

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.